                         SEQUENCE LISTING

<110>  Providence Health & Services - Oregon
 
<120>  CANCER THERAPEUTIC COMPOSITIONS AND METHODS TARGETING DNASE1L3

<130>  6727-104912-02

<150>  US 63/083,645
<151>  2020-09-25

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  1414
<212>  DNA
<213>  Homo sapiens

<400>  1
gccagaatcc agcactccaa gcactgctgt cttctcacag agtcttgaag ccagagcagc       60

gccaggatgt cacgggagct ggccccactg ctgcttctcc tcctctccat ccacagcgcc      120

ctggccatga ggatctgctc cttcaacgtc aggtcctttg gggaaagcaa gcaggaagac      180

aagaatgcca tggatgtcat tgtgaaggtc atcaaacgct gtgacatcat actcgtgatg      240

gaaatcaagg acagcaacaa caggatctgc cccatactga tggagaagct gaacagaaat      300

tcaaggagag gcataacgta caactatgtg attagctctc ggcttggaag aaacacatat      360

aaagaacaat atgcctttct ctacaaggaa aagctggtgt ctgtgaagag gagttatcac      420

taccatgact atcaggatgg agacgcagat gtgttttcca gggagccctt tgtggtctgg      480

ttccaatctc cccacactgc tgtcaaagac ttcgtgatta tccccctgca caccacccca      540

gagacatccg ttaaggagat cgatgagttg gttgaggtct acacggacgt gaaacaccgc      600

tggaaggcgg agaatttcat tttcatgggt gacttcaatg ccggctgcag ctacgtcccc      660

aagaaggcct ggaagaacat ccgcttgagg actgacccca ggtttgtttg gctgatcggg      720

gaccaagagg acaccacggt gaagaagagc accaactgtg catatgacag gattgtgctt      780

agaggacaag aaatcgtcag ttctgttgtt cccaagtcaa acagtgtttt tgacttccag      840

aaagcttaca agctgactga agaggaggcc ctggatgtca gcgaccactt tccagttgaa      900

tttaaactac agtcttcaag ggccttcacc aacagcaaaa aatctgtcac tctaaggaag      960

aaaacaaaga gcaaacgctc ctagacccaa gggtctcatc ttattaacca tttcttgcct     1020

ctaaataaaa tgtctctaac agatatgaac tgctccctgt acttaggaaa caagagtgat     1080

ccaactgctt tcattttttg acctgaattt attctgactt gagccaaatt ggaaggagaa     1140

tcttttgtat ctctcttggt ctcatacctc ccctgaattg tctaaaaggg aaccaggggc     1200

atttgtagac caaaatgatg atcttcatgc cctgagccag agccccatcc actgtcactg     1260

gccctgctca accctgtcat gcgagaggct gcagggggag gaagagcgtc agctttcagt     1320

cctcatgagg ggtcctgttc cacacgcaat gaccagaaac accaaggccc cagctgcccc     1380

tgtgatttgg gcaattaact gttttaagag tctg                                 1414


<210>  2
<211>  305
<212>  PRT
<213>  Homo sapiens

<400>  2

Met Ser Arg Glu Leu Ala Pro Leu Leu Leu Leu Leu Leu Ser Ile His 
1               5                   10                  15      


Ser Ala Leu Ala Met Arg Ile Cys Ser Phe Asn Val Arg Ser Phe Gly 
            20                  25                  30          


Glu Ser Lys Gln Glu Asp Lys Asn Ala Met Asp Val Ile Val Lys Val 
        35                  40                  45              


Ile Lys Arg Cys Asp Ile Ile Leu Val Met Glu Ile Lys Asp Ser Asn 
    50                  55                  60                  


Asn Arg Ile Cys Pro Ile Leu Met Glu Lys Leu Asn Arg Asn Ser Arg 
65                  70                  75                  80  


Arg Gly Ile Thr Tyr Asn Tyr Val Ile Ser Ser Arg Leu Gly Arg Asn 
                85                  90                  95      


Thr Tyr Lys Glu Gln Tyr Ala Phe Leu Tyr Lys Glu Lys Leu Val Ser 
            100                 105                 110         


Val Lys Arg Ser Tyr His Tyr His Asp Tyr Gln Asp Gly Asp Ala Asp 
        115                 120                 125             


Val Phe Ser Arg Glu Pro Phe Val Val Trp Phe Gln Ser Pro His Thr 
    130                 135                 140                 


Ala Val Lys Asp Phe Val Ile Ile Pro Leu His Thr Thr Pro Glu Thr 
145                 150                 155                 160 


Ser Val Lys Glu Ile Asp Glu Leu Val Glu Val Tyr Thr Asp Val Lys 
                165                 170                 175     


His Arg Trp Lys Ala Glu Asn Phe Ile Phe Met Gly Asp Phe Asn Ala 
            180                 185                 190         


Gly Cys Ser Tyr Val Pro Lys Lys Ala Trp Lys Asn Ile Arg Leu Arg 
        195                 200                 205             


Thr Asp Pro Arg Phe Val Trp Leu Ile Gly Asp Gln Glu Asp Thr Thr 
    210                 215                 220                 


Val Lys Lys Ser Thr Asn Cys Ala Tyr Asp Arg Ile Val Leu Arg Gly 
225                 230                 235                 240 


Gln Glu Ile Val Ser Ser Val Val Pro Lys Ser Asn Ser Val Phe Asp 
                245                 250                 255     


Phe Gln Lys Ala Tyr Lys Leu Thr Glu Glu Glu Ala Leu Asp Val Ser 
            260                 265                 270         


Asp His Phe Pro Val Glu Phe Lys Leu Gln Ser Ser Arg Ala Phe Thr 
        275                 280                 285             


Asn Ser Lys Lys Ser Val Thr Leu Arg Lys Lys Thr Lys Ser Lys Arg 
    290                 295                 300                 


Ser 
305 


